Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,161Revenue (TTM) $M175Net Margin (%)14.9Altman Z-Score9.6
Enterprise Value $M1,106EPS (TTM) $0.5Operating Margin %15.4Piotroski F-Score5
P/E(ttm)49.9Beneish M-Score-1.7Pre-tax Margin (%)15.6Higher ROA y-yN
Price/Book8.210-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales6.95-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow42.6y-y EBITDA Growth Rate %-26.9ROA % (ttm)14.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)21.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M49.5ROIC % (ttm)37.9Gross Margin Increase y-yN

Gurus Latest Trades with SUPN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SUPNRobert Bruce 2016-09-30 Reduce-0.35%$20.55 - $26.68
($22.63)
$ 23.454%Reduce -26.72%164,581
SUPNJoel Greenblatt 2016-09-30 Sold Out $20.55 - $26.68
($22.63)
$ 23.454%Sold Out0
SUPNJoel Greenblatt 2016-06-30 Reduce$15.12 - $20.37
($17.7)
$ 23.4532%Reduce -29.04%12,455
SUPNRobert Bruce 2016-03-31 Reduce-0.12%$10.13 - $15.65
($13.02)
$ 23.4580%Reduce -11.78%224,581
SUPNJoel Greenblatt 2016-03-31 Reduce$10.13 - $15.65
($13.02)
$ 23.4580%Reduce -48.08%17,552
SUPNRobert Bruce 2015-12-31 Reduce-0.57%$12.78 - $18.86
($15.48)
$ 23.4551%Reduce -35.48%254,581
SUPNJoel Greenblatt 2015-12-31 Reduce$12.78 - $18.86
($15.48)
$ 23.4551%Reduce -13.63%33,808
SUPNRobert Bruce 2015-09-30 Reduce-1.5%$13.62 - $21.26
($18.58)
$ 23.4526%Reduce -43.19%394,581
SUPNJoel Greenblatt 2015-09-30 Reduce-0.01%$13.62 - $21.26
($18.58)
$ 23.4526%Reduce -55.66%39,142
SUPNGeorge Soros 2015-06-30 Sold Out -0.01%$12.09 - $18.37
($14.2)
$ 23.4565%Sold Out0
SUPNJoel Greenblatt 2015-06-30 Add0.01%$12.09 - $18.37
($14.2)
$ 23.4565%Add 111.74%88,267
SUPNGeorge Soros 2015-03-31 Buy 0.01%$8.18 - $12.09
($9.45)
$ 23.45148%New holding107,308
SUPNJoel Greenblatt 2015-03-31 Buy $8.18 - $12.09
($9.45)
$ 23.45148%New holding41,686
SUPNRobert Bruce 2014-12-31 Add0.68%$7.49 - $9.49
($8.4)
$ 23.45179%Add 73.65%694,581
SUPNRobert Bruce 2014-09-30 Add0.73%$7.99 - $11.13
($8.98)
$ 23.45161%Add 300.00%400,000
SUPNRobert Bruce 2014-06-30 Buy 0.25%$7.32 - $10.85
($8.88)
$ 23.45164%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SUPN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SUPN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PATRICK GREGORY SVP, CFO 2016-09-16Sell2,000$25-6.2view
PATRICK GREGORY SVP, CFO 2016-07-14Sell3,395$226.59view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2016-04-11Sell30,762$16.4942.21view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-12-09Sell14,238$14.957.38view
BARRETT M JAMESDirector 2015-12-08Sell212,970$14.5661.06view
BARRETT M JAMESDirector 2015-11-25Sell16,179$16.3543.43view
BARRETT M JAMESDirector 2015-11-18Sell93,000$16.6141.18view
BARRETT M JAMESDirector 2015-11-16Sell119,650$16.2444.4view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-11-04Sell5,000$19.917.84view
Schwabe Stefan K.F.Executive Vice President R&D 2015-07-28Sell2,350$21.210.61view

Quarterly/Annual Reports about SUPN:

News about SUPN:

Articles On GuruFocus.com
Robert Bruce new Buys Feb 16 2015 
Third Quarter Was Robert Bruce's Busiest in 2014 Nov 21 2014 
Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 

More From Other Websites
Supernus misses 3Q revenue forecasts Jan 20 2017
Supernus misses 3Q revenue forecasts Jan 20 2017
SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q/A, Quarterly Report Jan 20 2017
Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US :... Jan 20 2017
Q4 Earnings Preview: Stocks Expecting 50% Or Higher Growth Jan 15 2017
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 06 2017
Supernus to Present at the 2017 J.P. Morgan Healthcare Conference Jan 03 2017
4 stocks to watch Dec 21 2016
The Bulls Don't Have Enough Juice for 20,000 Dec 20 2016
Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks Dec 19 2016
Stocks Higher As 3 Medicals Hit Buy Points; No 'Star Wars' Hasbro Bump Dec 19 2016
Is Precision Drilling Corp (USA) (PDS) A Good Stock To Buy? Dec 18 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 15 2016
Supernus Wins Appeal Case on Oxtellar XR® Dec 12 2016
Hedge Funds Are Crazy About Supernus Pharmaceuticals Inc (SUPN) Dec 02 2016
ETFs with exposure to Supernus Pharmaceuticals, Inc. : November 29, 2016 Nov 29 2016
Top Ranked Income Stocks to Buy for November 28th Nov 28 2016
Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SUPN-US :... Nov 28 2016
Why Earnings Season Could Be Great for Supernus (SUPN) Nov 21 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)